Tech Company Financing Transactions
Ceres Nanosciences Funding Round
On 2/4/2017, Ceres Nanosciences landed $3 million in Series A funding from Concord Ventures and GreyBird Ventures.
Transaction Overview
Company Name
Announced On
2/4/2017
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Concord Ventures (Lead Investor)
GreyBird Ventures (Tom Miller)
Proceeds Purpose
The firm is also working to help raise up to $9 million to complete the Series A round, which will be used to accelerate the market release of a highly sensitive diagnostic test for Lyme disease.
Company Information
Company Status
Private & Independent
Industry
Nanotechnology
Mailing Address
9460 Innovation Dr.
Manassas, VA 20110
USA
Manassas, VA 20110
USA
Phone
Website
Email Address
Overview
Ceres Nanosciences Inc. is engaged in the research, development, and commercialization of innovative sample preparation products and diagnostic tests, based on its proprietary Nanotrap particle platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ross Dunlap
Chief Technical Officer
Ben Lepene
VP - Bus. Development
Robbie Barbero
Browse more venture capital transactions:
Prev: 2/4/2017: Authess venture capital transaction
Next: 2/4/2017: Jobaline venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs